Adial Pharmaceuticals Stock Performance
| ADIL Stock | USD 1.45 0.25 20.83% |
The firm shows a Beta (market volatility) of -2.64, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Adial Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Adial Pharmaceuticals is expected to outperform it. Adial Pharmaceuticals has an expected return of -0.13%. Please make sure to confirm Adial Pharmaceuticals semi variance, day typical price, and the relationship between the maximum drawdown and accumulation distribution , to decide if Adial Pharmaceuticals performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Adial Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors. ...more
Last Split Factor 1:25 | Last Split Date 2023-08-07 |
1 | Acquisition by Claiborne Cary J of 1000000 shares of Adial Pharmaceuticals subject to Rule 16b-3 | 03/22/2024 |
2 | Acquisition by Tony Goodman of 42000 shares of Adial Pharmaceuticals at 1.35 subject to Rule 16b-3 | 03/25/2024 |
3 | Adial Pharmaceuticals, Inc. Short Interest Up 275.8 percent in March - Defense World | 03/28/2024 |
4 | Adial Pharmaceuticals, Inc. Forecasted to Post Q1 2024 Earnings of Per Share - Defense World | 04/05/2024 |
5 | Adial stock rallies 81 percent on data for alcohol abuse drug | 04/10/2024 |
6 | Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors Radars Today | 04/11/2024 |
7 | Acquisition by Schuyler Kevin of 12000 shares of Adial Pharmaceuticals at 1.35 subject to Rule 16b-3 | 04/15/2024 |
8 | Acquisition by Robertson Gilliland of 12000 shares of Adial Pharmaceuticals at 1.35 subject to Rule 16b-3 | 04/19/2024 |
9 | EXCLUSIVE Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patent | 04/22/2024 |
10 | Acquisition by Newman James W. Jr. of 10000 shares of Adial Pharmaceuticals at 2.66 subject to Rule 16b-3 | 04/26/2024 |
11 | ADIL Stock Earnings Adial Pharmaceuticals Misses EPS for Q1 2024 | 05/15/2024 |
12 | Acquisition by Anderson J. Kermit of 12000 shares of Adial Pharmaceuticals at 1.35 subject to Rule 16b-3 | 05/24/2024 |
13 | Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6th | 05/29/2024 |
| Begin Period Cash Flow | 4 M |
Adial |
Adial Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 275.00 in Adial Pharmaceuticals on March 4, 2024 and sell it today you would lose (130.00) from holding Adial Pharmaceuticals or give up 47.27% of portfolio value over 90 days. Adial Pharmaceuticals is currently does not generate positive expected returns and assumes 15.7069% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Adial, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Adial Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Adial Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Adial Pharmaceuticals, and traders can use it to determine the average amount a Adial Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0081
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ADIL |
Estimated Market Risk
| 15.71 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Adial Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adial Pharmaceuticals by adding Adial Pharmaceuticals to a well-diversified portfolio.
Adial Pharmaceuticals Fundamentals Growth
Adial Stock prices reflect investors' perceptions of the future prospects and financial health of Adial Pharmaceuticals, and Adial Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Adial Stock performance.
| Return On Equity | -1.9 | ||||
| Return On Asset | -0.82 | ||||
| Current Valuation | 3.01 M | ||||
| Shares Outstanding | 4.23 M | ||||
| Price To Earning | (1.88) X | ||||
| Price To Book | 2.31 X | ||||
| EBITDA | (6.89 M) | ||||
| Net Income | (7 M) | ||||
| Cash And Equivalents | 9.16 M | ||||
| Cash Per Share | 0.35 X | ||||
| Total Debt | 207.38 K | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 5.32 X | ||||
| Book Value Per Share | 2.46 X | ||||
| Cash Flow From Operations | (6.81 M) | ||||
| Earnings Per Share | (4.98) X | ||||
| Market Capitalization | 6.14 M | ||||
| Total Asset | 4.74 M | ||||
| Retained Earnings | (68.8 M) | ||||
| Working Capital | 2.99 M | ||||
| Current Asset | 1.02 M | ||||
| Current Liabilities | 452.53 K | ||||
About Adial Pharmaceuticals Performance
To evaluate Adial Pharmaceuticals Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Adial Pharmaceuticals generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Adial Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Adial Pharmaceuticals market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Adial's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.00 | 0.00 | |
| Return On Tangible Assets | (1.64) | (1.72) | |
| Return On Capital Employed | (1.69) | (1.77) | |
| Return On Assets | (1.64) | (1.72) | |
| Return On Equity | (1.90) | (1.99) |
Things to note about Adial Pharmaceuticals performance evaluation
Checking the ongoing alerts about Adial Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Adial Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Adial Pharmaceuticals generated a negative expected return over the last 90 days | |
| Adial Pharmaceuticals has high historical volatility and very poor performance | |
| Adial Pharmaceuticals may become a speculative penny stock | |
| Adial Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (7 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Adial Pharmaceuticals currently holds about 9.16 M in cash with (6.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.35. | |
| Adial Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6th |
- Analyzing Adial Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Adial Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Adial Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Adial Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Adial Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Adial Pharmaceuticals' stock. These opinions can provide insight into Adial Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adial Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Adial Stock please use our How to buy in Adial Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Adial Stock analysis
When running Adial Pharmaceuticals' price analysis, check to measure Adial Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adial Pharmaceuticals is operating at the current time. Most of Adial Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Adial Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adial Pharmaceuticals' price. Additionally, you may evaluate how the addition of Adial Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is Adial Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adial Pharmaceuticals. If investors know Adial will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adial Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.98) | Return On Assets (0.82) | Return On Equity (1.90) |
The market value of Adial Pharmaceuticals is measured differently than its book value, which is the value of Adial that is recorded on the company's balance sheet. Investors also form their own opinion of Adial Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Adial Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adial Pharmaceuticals' market value can be influenced by many factors that don't directly affect Adial Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adial Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adial Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adial Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.